Antiretroviral therapy may be associated with adverse effects that can affect adherence among people with HIV. This study aimed to describe the adverse effects of antiretroviral therapy and their association with treatment interruption among people with HIV followed at the Provincial General Reference Hospital of Bukavu, Democratic Republic of the Congo. A retrospective cross-sectional study was conducted using medical records of patients receiving antiretroviral therapy between January 2018 and January 2024. A total of 210 patients were included, with a median age of 44 years [35 - 52]. Female sex predominated (55.8%), with a sex ratio of 0.79 (M/F). Digestive disorders were the most frequently reported adverse effects. More than two-thirds of patients experienced at least one treatment interruption, with adverse effects being the most reported associated factor. Adverse effects were more frequently reported among patients receiving efavirenz-based regimens. These findings highlight that adverse effects are commonly reported and may be associated with treatment interruption, underscoring the importance of optimized monitoring and patient counseling to improve adherence.
Swinkels, H.M., Nguyen, A.D. and Gulick, P.G. (2025) HIV and AIDS. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK534860/
[3]
United Nations Programme on HIV/AIDS, Comité national de lutte contre le Sida, Programme National Multisectoriel de Lutte contre le Sida et Centre International d’Appui au Renforcement des Systèmes de Santé (2021) Baromètre analytique de la lutte contre le VIH/Sida en République démocratique du Congo. Progrès dans la ré-alisation des objectifs 95-95-95. https://www.unaids.org/sites/default/files/2021_RDC_barometre_fr.pdf
[4]
Programme National Multisectoriel de Lutte contre le Sida (2022) Rapport synthèse de l’état de la réponse de l’épidémie du VIH en RDC 2021. https://pnmls.cd/documentation/uploads/RAPPORT_SYNTHESE_2021_PNMLS.pdf
[5]
Cowan, E., Vail, R.M., Shah, S.S., et al. (2024) Diagnosis and Management of Acute HIV Infection. Johns Hopkins University.
[6]
Kausar, S., Said Khan, F., Ishaq Mujeeb Ur Rehman, M., Akram, M., Riaz, M., Rasool, G., etal. (2021) A Review: Mechanism of Action of Antiviral Drugs. InternationalJournalofImmunopathologyandPharmacology, 35, 1-12. https://doi.org/10.1177/20587384211002621
[7]
Endalamaw, A., Tezera, N., Eshetie, S., Ambachew, S. and Habtewold, T.D. (2018) Adherence to Highly Active Antiretroviral Therapy among Children in Ethiopia: A Systematic Review and Meta-Analysis. AIDSandBehavior, 22, 2513-2523. https://doi.org/10.1007/s10461-018-2152-z
[8]
Margolis, A.M., Heverling, H., Pham, P.A. and Stolbach, A. (2014) A Review of the Toxicity of HIV Medications. JournalofMedicalToxicology, 10, 26-39. https://doi.org/10.1007/s13181-013-0325-8
[9]
Montessori, V., Press, N., Harris, M., Akagi, L. and Montaner, J.S.G. (2004) Adverse Effects of Antiretroviral Therapy for HIV Infection. CanadianMedicalAssociationJournal, 170, 229-238.
[10]
(2016) Guide de prise en charge intégrée du VIH en République Démocratique du Con-go. Programme National de Lutte contre le Sida et les IST. https://www.pnmls.cd/documentation/uploads/guide-de-prise-en-charge-integree-du-vih-en-republique-democratique-du-congo.pdf
[11]
Map and Picture of Bukavu Town Showed HGPRB. https://www.google.ca/maps/search/carte+g%C3%A9ographique+de+l’h%C3%B4pital+provincial+de+bukavu/@-2.5167244,28.8342208,7599m/data=!3m1!1e3?hl=fr
[12]
Carr, A. and Cooper, D.A. (2000) Adverse Effects of Antiretroviral Therapy. TheLancet, 356, 1423-1430. https://doi.org/10.1016/s0140-6736(00)02854-3
[13]
Vermund, S.H. and Leigh-Brown, A.J. (2012) The HIV Epidemic: High-Income Countries. ColdSpringHarborPerspectivesinMedicine, 2, a007195. https://doi.org/10.1101/cshperspect.a007195
[14]
Izizag, B.B., Situakibanza, H., Kiazayawoko, F., Nkodila, A., Mafuta, E., Lukanu, P., etal. (2020) Déterminants de la non-observance au traitement antirétroviral chez l’adulte à Kinshasa. PanAfricanMedicalJournal, 37, Article No. 157. https://doi.org/10.11604/pamj.2020.37.157.13261
[15]
Karfo, R., Kabré, E., Coulibaly, L., Diatto, G., Sakandé, J. and Sangaré, L. (2018) Evolution des paramètres biochimiques et hématologiques chez les personnes vivant avec le VIH SIDA sous traitement antirétroviral au Centre Médical du Camp General Aboubacar Sangoule Lamizana (CMCGASL). PanAfricanMedicalJournal, 29, 2-5. https://doi.org/10.11604/pamj.2018.29.159.13659
[16]
Fiche d’information ONUSIDA 2022—Dernières statistiques sur l’état de l’épidémie de SIDA. https://www.unaids.org/fr/resources/fact-sheet
[17]
Alzai, M., Michaud, C., Lambrecht, L., Degrez, E., Ali, R. and Vernier, M. (2017) Suivi des femmes enceintes séropositives au VIH de janvier 2013 à décembre 2014 et de leurs nourrissons dans un département d’outre-mer. Médecine et Maladies Infectieuses, 47, S146. https://doi.org/10.1016/j.medmal.2017.03.353
[18]
Auvert, B., Taljaard, D., Lagarde, E., Sobngwi-Tambekou, J., Sitta, R. and Puren, A. (2005) Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial. PLOSMedicine, 2, e298. https://doi.org/10.1371/journal.pmed.0020298
[19]
Bailey, R.C., Moses, S., Parker, C.B., Agot, K., Maclean, I., Krieger, J.N., etal. (2007) Male Circumcision for HIV Prevention in Young Men in Kisumu, Kenya: A Randomised Controlled Trial. TheLancet, 369, 643-656. https://doi.org/10.1016/s0140-6736(07)60312-2
[20]
Traoré, A.M., Minta, D.K., Fomba, M., Cissé, H., Diallo, K., Coulibaly, I., et al. (2014) Profil épidémioclinique et évolutif de patients VIH positif, référés au CHU du Point G, Bamako, Mali. Bulletin de la Société de Pathologie Exotique, 107, 22-26. https://doi.org/10.1007/s13149-013-0322-9
[21]
Aubry, P. (2013) Infection par le VIH/Sida et tropiques Actualités 2012. Médecine Tropicale, 16 p. http://medecinetropicale.free.fr/sida_tropical.pdf
[22]
Deng, L., Li, C., Chen, P., Luo, X., Zheng, X., Zhou, L., et al. (2022) Dolutegravir plus Lamivudine versus Efavirenz Plus Tenofovir Disoproxil Fumarate and Lamivudine in Antiretroviral-Naive Adults with HIV-1 Infection. BMC Infectious Diseases, 22, Article No. 17. https://doi.org/10.1186/s12879-021-06991-y
[23]
Mu？oz-Moreno, J.A., Fumaz, C.R., Ferrer, M.J., et al. (2009) Sympt？mes neuropsychiatriques associés à l’efavirenz: Prévalence, corrélats et prise en charge. Une Revue Neurocomportementale, 11, 103-109.
[24]
Collinet, O. (2019) Facteurs associés à une mauvaise observance thérapeutique chez les patients vivant avec le VIH à l’h？pital Albert Schweitzer au Gabon en 2019. https://dumas.ccsd.cnrs.fr/dumas-02401977
[25]
PNLS (2016) Guide de prise en charge intégrée du VIH en République Démocratique du Congo. Version Révisée septembre.
